Last reviewed · How we verify
buccal infiltration of 4% Articaine with Epinephrine
buccal infiltration of 4% Articaine with Epinephrine is a Small molecule drug developed by Melaka Manipal Medical College. It is currently FDA-approved. Also known as: Septocaine 4%.
At a glance
| Generic name | buccal infiltration of 4% Articaine with Epinephrine |
|---|---|
| Also known as | Septocaine 4% |
| Sponsor | Melaka Manipal Medical College |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Comparison of Anesthetic Efficacy OF 2% Lidocaine Inferior Alveolar Nerve (IANB) Block Versus Primary Buccal Infilteration With 4% Articaine in Symptomatic Irreversible Pulpitis(SIP) IN Mandibular First Molars (NA)
- The Effect of Supplementary Foods Containing Trypsin, Chymotrypsin and Serratia Peptidase on Healing After Impacted Wisdom Tooth Surgery (NA)
- Assessment of Anesthetic Efficacy and Hemodynamic Stability of Two LA Drugs for Hypertensive Patients (NA)
- Pain and Anxiety in Pediatric Dentistry: Computer-Controlled vs. Traditional Anesthesia (NA)
- Effect of Dental Anxiety on Mandibular Anesthesia Success (NA)
- "Study of Pain Perception Using Computer-Controlled Versus Conventional Local Anaesthesia in Children Undergoing Molar Extraction (NA)
- Pain and Microbial Reduction of Antimicrobial Corticosteroid Mixture Versus Cryotherapy in Necrotic Teeth (NA)
- Effectiveness of Digital Anesthesia Versus Conventional Techniques in Reducing Pain and Anxiety in Children (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- buccal infiltration of 4% Articaine with Epinephrine CI brief — competitive landscape report
- buccal infiltration of 4% Articaine with Epinephrine updates RSS · CI watch RSS
- Melaka Manipal Medical College portfolio CI
Frequently asked questions about buccal infiltration of 4% Articaine with Epinephrine
What is buccal infiltration of 4% Articaine with Epinephrine?
buccal infiltration of 4% Articaine with Epinephrine is a Small molecule drug developed by Melaka Manipal Medical College.
Who makes buccal infiltration of 4% Articaine with Epinephrine?
buccal infiltration of 4% Articaine with Epinephrine is developed and marketed by Melaka Manipal Medical College (see full Melaka Manipal Medical College pipeline at /company/melaka-manipal-medical-college).
Is buccal infiltration of 4% Articaine with Epinephrine also known as anything else?
buccal infiltration of 4% Articaine with Epinephrine is also known as Septocaine 4%.
What development phase is buccal infiltration of 4% Articaine with Epinephrine in?
buccal infiltration of 4% Articaine with Epinephrine is FDA-approved (marketed).
Related
- Manufacturer: Melaka Manipal Medical College — full pipeline
- Also known as: Septocaine 4%
- Compare: buccal infiltration of 4% Articaine with Epinephrine vs similar drugs
- Pricing: buccal infiltration of 4% Articaine with Epinephrine cost, discount & access